Meeting Post-Marketing Surveillance Requirements For New Vaccines In The COVID Era

With several promising COVID-19 vaccine candidates approaching regulatory approval, manufacturers are preparing for essential post-marketing evaluations of long-term safety and effectiveness in real-world patient populations. The unprecedented scale and criticality of current vaccine development demands modern, evidence-driven safety surveillance and monitoring solutions that capitalize on the benefits of today’s digitization of healthcare data, which includes speed, reproducibility and easy access to the health information of large, diverse, exposed patient populations.

Powered by real world evidence (RWE), UBC’s surveillance solutions are uniquely equipped to ensure your organization’s readiness to meet the urgent post-marketing requirements of your new vaccine.